BAT discloses internal share transfer by senior research director

An update from British American Tobacco ( (GB:BATS) ) is now available.

British American Tobacco has disclosed a transaction involving James Murphy, its Director of Research and Science, under regulatory rules for persons discharging managerial responsibilities. The filing records an internal transfer of 12,283 ordinary shares between Murphy’s own accounts for no consideration, conducted outside a trading venue on 30 March 2026.

While the move does not alter the total number of shares in issue or signal a change in incentive structures, it highlights ongoing governance transparency around senior executives’ holdings. Such notifications are closely watched by investors as part of routine scrutiny of insider share movements and alignment of management interests with shareholders.

The most recent analyst rating on (GB:BATS) stock is a Hold with a £41.50 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.

Spark’s Take on BATS Stock

According to Spark, TipRanks’ AI Analyst, BATS is a Outperform.

The score is driven primarily by solid-but-not-clean financial performance (profitability strength offset by leverage and a notable 2025 cash-flow decline). Valuation is supportive due to the high dividend yield and moderate P/E, while technicals are broadly neutral. Earnings-call guidance and capital-return plans help, but are tempered by vapor/illicit pressures and regional weakness.

To see Spark’s full report on BATS stock, click here.

More about British American Tobacco

British American Tobacco p.l.c. is a global tobacco company whose primary products include cigarettes and other nicotine offerings. The group is listed in London and operates through a broad international footprint, with its shares actively held and traded by institutional and individual investors in major capital markets.

Average Trading Volume: 4,262,763

Technical Sentiment Signal: Buy

Current Market Cap: £94.71B

For a thorough assessment of BATS stock, go to TipRanks’ Stock Analysis page.